Biohaven Pharmaceuticals
- Meghan Lovegren
Meghan Lovegren
Director, Clinical Operations at Biohaven Pharmaceuticals
Meghan Lovegren is approaching 20 years of experience in clinical research. Prior to joining Biohaven, Meghan managed clinical studies in genetic diseases (Duchenne Muscular Dystrophy) and virology (HBV and HCV) at Bristol-Myers Squibb for 12 years. At BMS, Meghan ran global pivotal studies in both pediatric and adult populations. Prior to BMS, Meghan worked at Pfizer, Yale University and Memorial Sloan-Kettering Cancer Center. She has a BS in Biology from the University of Minnesota, College of Biological Sciences.
Timeline
Director, Clinical Operations
Current role
Related people
Yuki Prescott
Director, Clinical Operations at Arrivo BioVentures
Joseph Gilbert
Director, Clinical Operations at Kedalion Therapeutics
Meriza Viray
Director, Clinical Operations at Excision BioTherapeutics
Silvia Cermelli
Director, Clinical Operations at Immunexpress
Kathleen Marcozzi Pierce
Director, Clinical Operations at Acumen Pharmaceuticals